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Abstract
Following a request from the European Commission, the European Food Safety Authority Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc
opinion on the safety and efﬁcacy of Probiotic Lactina® for chickens for fattening and rabbits. The
additive is a preparation containing viable cells of six strains of lactic acid bacteria intended for use in
feed at the proposed dose of 2.5 9 109 CFU/kg complete feedingstuffs. The identity of all of the
component strains of Probiotic Lactina® was established in a previous opinion, ﬁve of which qualify for
the qualiﬁed presumption of safety (QPS) approach to safety assessment. As no antibiotic resistance of
concern was detected in these strains, following the QPS approach, the use of these ﬁve strains in
feedingstuffs is presumed safe for target species; consumers of products from animals fed the additive
and the environment. The identity and safety of the sixth strain, Enterococcus faecium NBIMCC 8270,
was also established in the previous and current opinions. The FEEDAP Panel concludes that Probiotic
Lactina® is safe for rabbits (suckling and weaned) at the recommended inclusion level of 2.5 9 109
CFU/kg feed and reiterates its former conclusion that the product is safe for chickens for fattening at
1 9 1010 CFU/kg feed. The FEEDAP Panel considers Probiotic Lactina® to be safe for consumers of
products derived from treated animals when used at the conditions proposed. In the absence of data,
the FEEDAP Panel cannot conclude on the irritancy of Probiotic Lactina® to skin and eyes or on its
dermal sensitisation. Owing to the proteinaceous nature of the active agents, the additive is
considered to be a potential respiratory sensitiser. No conclusions can be drawn on the efﬁcacy of
Probiotic Lactina® for chickens for fattening and rabbits (suckling/weaned).
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Lactina Ltd.2 for authorisation of the Probiotic
Lactina® (Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus NBIMCC 8242, Lactobacillus
helveticus NBIMCC 8269, Lactobacillus delbrueckii ssp. lactis NBIMCC 8250, Lactobacillus delbrueckii
ssp. bulgaricus NBIMCC 8244 and Streptococcus thermophilus NBIMCC 8253), when used as a feed
additive for rabbits (suckling and weaned) and chickens for fattening (category: zootechnical additives;
functional group: gut ﬂora stabilisers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 6 July 2017.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Probiotic Lactina® (Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus NBIMCC
8242, Lactobacillus helveticus NBIMCC 8269, Lactobacillus delbrueckii ssp. lactis NBIMCC 8250,
Lactobacillus delbrueckii ssp. bulgaricus NBIMCC 8244 and Streptococcus thermophilus NBIMCC 8253),
when used under the proposed conditions of use (see Section 3.1.1).
1.2. Additional information
Probiotic Lactina® is a feed additive consisting of viable cells of six strains of lactic acid bacteria.
EFSA has issued one opinion on the use of this additive in chickens for fattening, piglets (suckling and
weaned) and pigs for fattening which raised questions on the product characterisation, safety for the
target species, consumers and users, and on the efﬁcacy (EFSA, 2008). The issues relating to
characterisation of the active agent and of the additive and its safety were satisfactorily addressed in a
second opinion for chickens for fattening and weaned and suckling piglets. However, the efﬁcacy for
chickens for fattening and weaned piglets could not be demonstrated (EFSA FEEDAP Panel, 2013). In
the context of the same application, the request for authorisation of Probiotic Lactina® for pigs for
fattening was withdrawn.
The additive is currently authorised as a zootechnical additive (functional group: gut ﬂora
stabilisers) only for use in feed for suckling piglets.3
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of Probiotic Lactina® as a feed additive.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agents in animal feed. The Executive Summary of the EURL
report can be found in Annex A.5
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Lactina Ltd., Soﬁa str 101,1320, Banky, Bulgaria.
3 Commission Implementing Regulation (EU) No 1077/2013 of 31 October 2013 concerning the authorisation of a preparation of
Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus NBIMCC 8242, Lactobacillus helveticus NBIMCC 8269,
Lactobacillus delbrueckii ssp. lactis NBIMCC 8250, Lactobacillus delbrueckii ssp. bulgaricus NBIMCC 8244, and Streptococcus
thermophilus NBIMCC 8253 as a feed additive for suckling piglets (holder of authorisation Lactina Ltd). OJ L 292, 1.11.2013, p. 3.
4 FEED dossier reference: FAD-2017-0003.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports/fad-2017-
0003?search&form-return
Probiotic Lactina® for chickens and rabbits
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2019;17(3):5646
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Probiotic
Lactina® is in line with the principles laid down in Regulation (EC) No 429/20086, the relevant
guidance documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical
guidance on tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011) and Guidance
on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance
(EFSA FEEDAP Panel, 2012b).
3. Assessment
Probiotic Lactina® is a preparation of viable cells of six strains of lactic acid bacteria (LAB) intended
for use as a zootechnical additive (gut ﬂora stabiliser) in feeds for rabbits (suckling and weaned) and
chickens for fattening to improve their performance.
3.1. Characterisation
3.1.1. Characterisation of the additive
The product is a mixture of L. acidophilus NBIMCC 8242, L. delbrueckii ssp. lactis NBIMCC 8250,
L. delbrueckii ssp. bulgaricus NBICCM 8244, L. helveticus NBIMCC 8269, S. thermophilus NBIMCC 8253
and E. faecium NBIMCC 8270 in a 1:1:1:1:1:1 ratio on a colony forming units (CFU)/g basis, with a
total content of 5 9 109 CFU LAB/g. It has the same formulation: 60% bacterial mass, spent medium
and cryoprotectants, 20% glucose, 10% inulin and 10% calcium carbonate, with the exception of the
replacement of glucose with polydextrose, and method of manufacture as that considered in previous
applications (EFSA, 2008; EFSA FEEDAP Panel, 2013). Thus, the data pertaining to impurities, physical
properties, shelf life and stability in feed for chickens still apply. However, some new information has
been provided in the current dossier which is described below.
In a previous opinion (EFSA FEEDAP Panel, 2013), the susceptibility of all strains to relevant
antibiotics was tested according to the provisions of the Guidance on the assessment of bacterial
susceptibility to antimicrobials of human and veterinary importance (EFSA, 2008). In that instance, the
six strains proved to be susceptible to all the relevant antibiotics listed in the guidance. This conclusion
is still considered to be valid. However since then, the FEEDAP Panel introduced a new requirement for
testing the susceptibility of E. faecium NBIMCC 8270 to tylosin (EFSA FEEDAP Panel, 2012b). The
minimum inhibitory concentration (MIC) value of the E. faecium strain to tylosin was measured by
broth microdilution following the method of the Clinical and Laboratory Standards Institute (CLSI).7
The MIC value found fell below the corresponding FEEDAP cut-off value (MIC: 2 mg/L vs cut-off value:
4 mg/L), consequently, the strain is considered susceptible to tylosin.
Three batches of Probiotic Lactina® were analysed for the heavy metals and arsenic content.8
Results showed values for lead (0.030, 0.037 and 0.046 mg/kg), mercury (0.0073, 0.0077 and
0.0084 mg/kg), cadmium (< 0.00045, 0.0092 and 0.012 mg/kg), copper (0.625, 0.0635 and
0.779 mg/kg) and arsenic (0.0240, 0.0345 and 0.394 mg/kg) that do not raise safety concerns.
An analysis of the dusting potential of one batch of the additive (four repetitions), using the
Stauber–Heubach method, showed a mean value of 0.7 g/m3.9
3.1.2. Stability and homogeneity
The applicant declares that the product is not suitable for use in premixtures and provides an
analysis supporting this statement.10 Losses in counts of total LAB were greater than 0.5 log when the
additive was mixed at 3 9 1010 CFU/kg in two vitamins and minerals premixtures, and stored for
1 month at 23°C/70% relative humidity (RH).
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
7 Technical dossier/Supplementary information May 2018/Report on the antimicrobial susceptibility of Enterococcus faecium
NBIMCC 8270 to tylosin.
8 Technical dossier/Supplementary information May 2018.
9 Technical dossier/Section II/Annex II.8.
10 Technical dossier/Section II/Annex II.15.
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Stability to pelleting process was measured in three batches of the additive incorporated in a mash
feed for rabbits at 3.6 9 109 CFU/kg feed (700 mg/kg feed) and subject to pelleting (barrel
temperature 125°C, moisture content 16% and feed rate 9 Hz).11 Results showed negligible losses
after the pelleting process on total LAB counts and on individual counts, except for L. bulgaricus
NBICCM 8244 and L. lactis NBIMCC 8250 where the losses reached approximately 0.5 log units. The
same samples of pelleted feed were stored at 18°C/70% RH for 3 months and subject to total LAB and
individual counts. Losses after this period were negligible (< 0.5 log units).
In another study, the stability of the additive (three batches) was tested when incorporated in a
pelleted feed (after pelleting) for rabbits at 500 mg/kg feed (9 9 109 CFU/kg feed) and stored at
23°C/70% RH for 3 months.10 However, in the absence of differential counts, it is not possible to
determine whether equal sensitivity was shown by all strains in the additive or whether one or more
component strains were particularly sensitive.
A total of 30 subsamples were taken from three batches of mash feed for rabbits (10 subsamples
per feed) at regular intervals after mixing with the additive.12 The total LAB counts showed a
coefﬁcient of variation was 2%, demonstrating homogeneous mixing.
3.1.3. Conditions of use
Probiotic Lactina® is intended for rabbits (suckling and weaned) and for chickens for fattening at
the minimum dose of 2.5 9 109 CFU/kg complete feedingstuffs.
The applicant declares that the product is not suitable for use in premixtures.
3.2. Safety
The species L. acidophilus, L. delbrueckii, L. helveticus and S. thermophilus are considered by EFSA
to be suitable for the qualiﬁed presumption of safety (QPS) approach to establishing safety for the
target species, consumers and the environment (EFSA, 2007; EFSA BIOHAZ Panel, 2017). In previous
opinions (EFSA, 2008 and EFSA FEEDAP Panel, 2013) the identiﬁcation of the strains and compliance
with the QPS qualiﬁcations were conﬁrmed. Therefore, the Panel concluded that L. acidophilus
NBIMCC 8242, L. helveticus NBIMCC 8269, L. delbrueckii ssp. lactis NBIMCC 8250, L. delbrueckii ssp.
bulgaricus NBIMCC 8244 and S. thermophilus NBIMCC 8253 can be presumed safe for target animals,
consumers of products derived from animals fed the additive and the environment. This presumption
does not extend to the sixth strain (E. faecium).
3.2.1. Safety for the target species
In the opinion from 2013, E. faecium NBIMCC 8270 was recognised as non-pathogenic for chickens
(EFSA FEEDAP Panel, 2013). In addition, oral dosing of these species with the Probiotic Lactina® did not
elicit any detectable adverse responses or adversely affect growth of chickens for fattening. Therefore,
the additive was considered safe for chickens for fattening to a maximum of 1 9 1010 CFU/kg complete
feed.
The applicant produced a tolerance trial involving 12 female rabbits (New Zealand White)
distributed based on age and parity into four groups, and their offspring (three replicates per
treatment).13 A basal diet based on lucerne meal/oat/wheat bran/soybean meal/barley and sunﬂower
meal alone (control) or supplemented with increasing amounts of the additive was used. The feed was
pelleted after inclusion of the additive and animals were given a coccidiostat (toltrazuril, not authorised
for this use in the European Union (EU)) through the water during 2 days after weaning. The use
levels of the additive are expressed in g/kg feed and correspond to 0, 29 the recommended dose, 29
the recommended dose and 200x the recommended dose. Compliance of the batch of the additive
used with the speciﬁcations and concentration of the additive in the supplemented feeds were
conﬁrmed by analysis. Measured values were: 5.2 9 109, 2.6 9 1010 and 2.5 9 1011 CFU LAB/kg feed.
Animals remained in the same treatment groups until the end of the experiment, at 77 days of age. At
birth the treatment groups were composed of 22, 24, 22 and 23 rabbits, respectively. Animals were
sexed at weaning (at 35 days), resulting in 12 males and 8 females in the control group, 9 males and
11 Technical dossier/Supplementary information May 2018/Supplementary information Application for authorization of Probiotic
Lactina.
12 Technical dossier/Supplementary information May 2018/Report on the results of the conducted test of homogeneity of the
feed additive Lactina in mash feed for rabbits.
13 Technical dossier/Section III/Annex III.1 and Supplementary information July 2018.
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12 females in the 29 group, 11 males and 7 females in the 209 group and 12 males and 11 females
in the 2009 group. At weaning, rabbits were also distributed in three cages (of 7/8 rabbits) within
treatment groups, representing the replicates. Rabbits were individually weighed on days 1, 7, 35 and
77. Feed consumption was measured on a cage basis and feed to gain ratio was calculated. Morbidity
and mortality were monitored in the overall period. Four rabbits per treatment were necropsied for
gross pathology. Data are analysed with an analysis of variance (ANOVA).
Mortality was normal and not treatment related (two animals died in the control group, three in the
29 group and three in the 209 group). At the end of the experiment, no signiﬁcant differences were
observed on body weight (control: 1.98 kg, 29 group: 2.01 kg, 209 group: 2.32 kg and 2009 group:
2.26 kg) or feed intake (control: 75.4 g, 29 group: 72.3 g, 209 group: 79.6 g and 2009 group:
80.1 g). But a signiﬁcant difference was observed on the feed to gain ratio between the 29 group and
the control group, in favour of the treated group (control: 2.96, 29 group: 2.78, 209 group: 2.73 and
2009 group: 2.78, p < 0.05). No adverse effects were observed during the necropsy.
The tolerance trial described above presented weaknesses, in particular, the use of only three
replicates per treatment. The inclusion of a coccidiostat not authorised in the EU would not correspond
to the EU farming practices. However, toltrazuril is not an ionophore, and thus, is not expected to
interfere with the gut microbiota. Therefore, taking also into consideration that:
• ﬁve of the six strains assessed using the QPS approach are presumed safe for target animals,
• the sixth strain, E. faecium, is not a recognised pathogen for rabbits, it lacks the marker genes
associated with human clinical isolates and is susceptible to relevant antibiotics,
• the end-products of the metabolism of the species are typical of lactic acid bacteria, and do
not raise concerns,
• the additive does not contain excipients of concern, and
• the additive at approximately 200 times the recommended dose, did not adversely affect the
health or growth of rabbits,
the FEEDAP Panel concludes that Probiotic Lactina® is safe for rabbits at the recommended inclusion
level.
3.2.2. Safety for the consumer
In the previous opinion (EFSA FEEDAP Panel, 2013), E. faecium NBIMCC 8270 was found to be
susceptible to clinically relevant antibiotics and to lack the marker genes typical of hospital-associated
isolates responsible for clinical infections. The metabolism of E. faecium is well known and when the
potential for infection is excluded, no other harmful metabolites or substances are expected to be
produced during fermentation. Consequently, as no safety issues relating to the active agents were
identiﬁed, and as the additive does not contain excipients of concern, the FEEDAP Panel considered
Probiotic Lactina® to be safe for consumers when used under the conditions proposed. The new data
on the susceptibility of one of the active agents to tylosin provided (see Section 3.1.1), conﬁrm
previous conclusions that Probiotic Lactina® can be considered safe for consumers of products derived
from treated animals.
3.2.3. Safety for the user
In the opinion from 2008, the Panel concluded that owing to the proteinaceous nature of the active
agents, the possibility for the additive to act as a respiratory sensitiser cannot be excluded (EFSA,
2008). No information on inhalation toxicity, skin/eye irritation or skin sensitisation of the additive has
been provided. In the absence of data, the FEEDAP Panel cannot conclude on the irritancy of Probiotic
Lactina® to skin and eyes or on its dermal sensitisation. Owing to the proteinaceous nature of the
active agents, the additive is considered to be a potential respiratory sensitiser.
3.2.4. Safety for the environment
In the opinion from 2008, the Panel concluded that the bacteria present in the product are
common species in foods and/or in the intestinal tract of animals, and their use in the product is not
likely to increase their presence in the wider environment (EFSA, 2008). Consequently, no risks for the
environment are expected from the use of this product. The Panel considers that these conclusions
apply also to the current application.
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3.3. Efﬁcacy
3.3.1. Efﬁcacy for chickens for fattening
The applicant provided three studies performed in the same Member State but in two different
locations to identify the effective dose of Probiotic Lactina® in improving chickens’ performance.
The design of the studies is presented in Table 1 and the results in Table 2. In all cases, 1-day-old
birds (Ross 308, males in study 114 and females in studies 215 and 316) were allocated to four
treatment groups: a control group receiving the basal diet alone (control) and other three groups
receiving the same basal diet supplemented with the additive at the recommended inclusion level
(2.5 9 109 CFU/kg complete feedingstuffs) or at other concentrations (Table 1). The use levels were
calculated in grams of additive per kg of feed. Compliance of the batch used with the speciﬁcations
(5.5 9 109 CFU LAB/g in study 1, 6 9 109 CFU LAB/g in study 2 and 6.5 9 109 CFU LAB/g in study 3)
and of the intended concentration of the additive in the supplemented feeds were conﬁrmed by
analysis (Table 2). The diets were offered to the animals ad libitum. Birds were weighed individually on
days 1, at change of feed (on days 12 and 27 in study 1 and 14 and 28 in studies 2 and 3) and at the
end of the trial. Feed consumption was measured on a pen basis and feed to gain ratio calculated.
Morbidity and mortality were monitored in the overall period. Data were statistically analysed with an
ANOVA using the pen as experimental unit for all the parameters tested. Means were separated with
Tukey Honestly-signiﬁcant-difference (HSD), Scheffe, Dunnett t-, Games-Howell and/or Tamhane tests.
Table 1: Details on the study design for the studies performed in chickens for fattening
Study
No
Duration
(days)
Total animals
Replicates/
treatment
3
animals/
replicate
Intended
concentration of
Probiotic Lactina® in
feed
(CFU LAB/kg feed)
Analysed
concentration of
Probiotic Lactina® in
feed
(CFU LAB/kg feed)
Basal diets
(main ingredients)
form
1
(40)
120
3 9 10
0
1.5 9 109
2.5 9 109
3.5 9 109
0
1.5 9 109
2.5 9 109
3.6 9 109
Starter, grower and ﬁnisher
(maize/soybean meal/wheat)
mash
2
(42)
120
3 9 10
0
2.5 9 109
5.0 9 1010
5.0 9 1011
0
2.6 9 109
5.5 9 1010
5.4 9 1011
Starter, grower and ﬁnisher
(maize/wheat/
soybean groats
mash
3
(42)
120
3 9 10
0
2.5 9 109
5.0 9 1010
5.0 9 1011
0
2.7 9 109
5.0 9 1010
5.2 9 1011
Starter, grower and ﬁnisher
(maize/soybean groats/
wheat)
mash
CFU: colony forming unit; LAB: lactic acid bacteria.
14 Technical dossier/Section IV/Annex IV.4 and Supplementary information May 2018/Annexes_Statistical analysis chickens and
Question 11.
15 Technical dossier/Section IV/Annex IV.5 and Supplementary information May 2018/Annexes_Statistical analysis_chickens and
Question 11.
16 Technical dossier/Section IV/Annex IV.6 and Supplementary information May 2018/Annexes_Statistical analysis_chickens and
Question 11.
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Mortality was low and not treatment related. The design of the studies is weak due to the small
number of replicates included. Feed to gain ratio was signiﬁcantly improved in one study at the
recommended inclusion level and at a greater concentration (study 1) and in another study at a much
greater inclusion level (5.0 9 1011 CFU/kg feed, study 2), compared to control. Therefore, there is
insufﬁcient evidence to conclude on the efﬁcacy of Probiotic Lactina® at any dose in chickens for
fattening.
3.3.2. Efﬁcacy for suckling and weaned rabbits
The applicant provided three studies performed in the same Member State but in two different
locations. The studies were aimed at demonstrating the effects of Probiotic Lactina on rabbits’
performance.
The design of the studies is presented in Table 3 and the results in Table 4. The trials shared the
same experimental design in which 12 female rabbits, and their offspring, were distributed based on
age and parity into four or ﬁve groups receiving the same basal diet alone (control) or supplemented
with the additive at the recommended inclusion level and at other concentrations (Table 3).
Compliance of the batch of the additive used with the speciﬁcations and concentration of the additive
in the supplemented feeds were conﬁrmed by analysis (Table 4). Feed was pelleted after inclusion of
the additive. The coccidiostat toltrazuril (not authorised for this use in the EU) was added to drinking
water during 2 days after weaning. The diets were offered to the animals ad libitum. Animals
remained in the same treatment groups until the end of the experiment (at 77 days of age). Each
mother and her offspring represented a replicate. Rabbits were sexed at weaning at 35 days and
moved to cages. Individual bodyweight was measured on days 1, 7, 35 and at the end of the trial on
day 77. Feed consumption was measured on a pen basis and feed to gain ratio calculated. Morbidity
and mortality were monitored in the overall period. Data were statistically analysed with an ANOVA
using the pen as experimental unit for all the parameters tested. Means were separated with Tukey
HSD, Scheffe, Dunnett t-, Games-Howell and/or Tamhane tests.
Table 2: Effect of Probiotic Lactina® on the zootechnical performance of chickens for fattening
Study
No
Intended concentration
of Probiotic Lactina®
in feed
(CFU LAB/kg feed)
Daily feed
intake
(g)
Final body
weight
(g)
Daily body
weight gain
(g/bird)
Feed to
gain ratio
Mortality
(n)
1 0 99.5 2,112 51.7 1.93 0
1.5 9 109 99.9 2,194 53.7 1.87 1
2.5 9 109 98.3 2,205 54.0 1.82* 0
3.5 9 109 96.1 2,169 53.1 1.81* 0
2 0 81.3 1,844 42.9 1.90 0
2.5 9 109 81.3 1,989 46.3 1.76 1
5.0 9 1010 80.7 1,904 44.3 1.82 1
5.0 9 1011 82.0 1,968 45.8 1.79* 0
3 0 74.4 1,744 40.6 1.84 0
2.5 9 109 74.7 1,834 43.0 1.76 0
5.0 9 1010 74.9 1,794 41.7 1.87 0
5.0 9 1011 76.8 1,786 41.6 1.91 0
CFU: colony forming unit; LAB: lactic acid bacteria.
*: Means in a column within a given trial are signiﬁcantly different from control by at least p < 0.05.
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Mortality was not treatment related. The reporting of the studies was poor despite the requests for
completion, and the design weak due to the small number of replicates included. The rabbits receiving
the additive showed a signiﬁcantly greater body weight at the end of the trial in one study at an
inclusion level close to the intended one (study 2) and at a much greater level (7.0 9 1011 CFU/kg
feed) in the same study and in a second one (study 3), compared to control. Therefore, there is
insufﬁcient evidence to conclude on the efﬁcacy of Probiotic Lactina® in rabbits.
Table 3: Details on the study design for the studies performed in rabbits
Study
No
Breed
Total animals
Replicates/
treatment
3
animals/
replicate
Intended Probiotic
Lactina concentration in
feed (CFU LAB/kg feed)
Analysed
concentration of
Probiotic Lactina in
feed
(CFU/kg feed)
Basal diets
(main ingredients)
form
1(a) White New
Zealand
rabbit
♀,♂
74
3 9 4–5
0
1.5 9 109
2.5 9 109
3.5 9 109
5 9 109
0
1.6 9 109
2.5 9 109
3.6 9 109
5 9 109
Lucerne meal/oat/
wheat whole meal/
barley/soybean meal
groats
Mash and granulated
2(b) Californian
rabbit
♀,♂
88
3 9 6–8
0
3.5 9 109
7.0 9 1010
7.0 9 1011
0
2.6 9 109
5.0 9 1010
5.4 9 1011
Lucerne meal/oat/
wheat bran/barley/
soybean meal
Pelleted
3(c) Californian
rabbit
♀,♂
85
3 9 6–8
0
3.5 9 109
7.0 9 1010
7.0 9 1011
0
2.8 9 109
2.7 9 1010
2.5 9 1011
Lucerne meal/oat/
wheat bran/barley/
soybean meal
Pelleted
CFU: colony forming unit; LAB: lactic acid bacteria.
(a): Technical dossier/Section IV/Annex IV.1.
(b): Technical dossier/Section IV/Annex IV.2.
(c): Technical dossier/Section IV/Annex IV.3.
Table 4: Effect of Probiotic Lactina® on the zootechnical performance of rabbits
Study
No
Intended
concentration
of Probiotic Lactina
in feed
(CFU/kg feed)
Daily feed
intake (g)
Final
weight (g)
Daily body
weight
gain
(g/rabbit)(a)
Feed to
gain
ratio(b)
Mortality
(n/N)
1 0 118.3 2,200 n.r. 3.38 1/15
1.5 9 109 107.0 2,242 n.r. 3.02 1/14
2.5 9 109 117.4 2,333 n.r. 2.92 0
3.5 9 109 117.4 2,402 n.r. 2.84 0
5 9 109 112.7 2,401 n.r. 2.72 0
2 0 77.6 1,980 25.0 3.05 2/20
3.5 9 109 77.3 2,113* 26.7 2.83 3/25
7.0 9 1010 78.5 2,165 27.4 2.87 0
7.0 9 1011 79.3 2,225* 28.2 2.80 1/22
3 0 76.7 2,006 26.3 2.91 0
3.5 9 109 75.5 2,057 26.6 2.84 0
7.0 9 1010 76.1 2,091 27.1 2.80 0
7.0 9 1011 77.5 2,117* 28.0* 2.77 0
CFU: colony forming unit; LAB: lactic acid bacteria; n.r.: not reported.
*: Means in a column within a given trial are signiﬁcantly different from control by at least p < 0.05.
(a): In study 2 not statistically analysed.
(b): In studies 2 and 3 not statistically analysed.
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3.3.2.1. Conclusions on efﬁcacy for the target species
No conclusions could be drawn on the efﬁcacy of Probiotic Lactina® for rabbits (suckling/weaned)
and chickens for fattening based on the data provided.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation17 and Good
Manufacturing Practice.
4. Conclusions
The identity of all component strains of Probiotic Lactina® was established in a previous opinion,
ﬁve of which qualify for the QPS approach to safety assessment. As no antibiotic resistance of concern
was detected in these strains, following the QPS approach, their use in feedingstuffs is presumed safe
for the target species, consumers of products from animals fed the additive and the environment. The
identity and safety of the sixth strain, E. faecium NBIMCC 8270, was also established in the previous
and current opinions.
The FEEDAP Panel concludes that Probiotic Lactina® is safe for rabbits (suckling and weaned) at
the recommended inclusion level of 2.5 9 109 CFU/kg feed and reiterates its former conclusion that
the product is safe for chickens for fattening at 1 9 1010 CFU/kg feed.
The FEEDAP Panel considers Probiotic Lactina® to be safe for consumers of products derived from
treated animals when used at the conditions proposed.
In the absence of data, the FEEDAP Panel cannot conclude on the irritancy of Probiotic Lactina® to
skin and eyes or on its dermal sensitisation. Owing to the proteinaceous nature of the active agents,
the additive is considered to be a potential respiratory sensitiser.
No conclusions can be drawn on the efﬁcacy of Probiotic Lactina® for chickens for fattening and
rabbits (suckling/weaned).
Documentation provided to EFSA
1) Probiotic Lactina®. January 2017. Submitted by Lactina Ltd.
2) Probiotic Lactina®. Supplementary information. May 2018. Submitted by Lactina Ltd.
3) Probiotic Lactina®. Supplementary information. July 2018. Submitted by Lactina Ltd.
4) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Probiotic Lactina®.
5) Comments from Member States.
Chronology
Date Event
04/01/2017 Dossier received by EFSA
19/01/2017 Reception mandate from the European Commission
06/07/2017 Application validated by EFSA – Start of the scientiﬁc assessment
24/10/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation and efﬁcacy
19/09/2017 Reception of the Evaluation report of the European Union Reference Laboratory for Feed Additives
06/10/2017 Comments received from Member States
22/05/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
17/07/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended Issues: Safety for the target species
25/07/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
27/02/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
17 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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ANOVA analysis of variance
CFU colony forming unit
CLSI Clinical and Laboratory Standards Institute
CV coefﬁcient of variation
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HSD Honestly-signiﬁcant-difference
IDF International Dairy Federation
LAB lactic acid bacteria
MIC minimum inhibitory concentration
PFGE pulsed ﬁeld gel electrophoresis
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Methods of Analysis
for Probiotic Lactina®
Probiotic lactina® is the trade name of a preparation based on viable cells from acid lactic bacteria
(LAB) containing the following six strains: Enterococcus faecium NBIMCC 8270, Lactobacillus acidophilus
NBIMCC 8242, Lactobacillus helveticus NBIMCC 8269, Lactobacillus delbrueckii ssp. lactis NBIMCC 8250,
Lactobacillus delbrueckii ssp. bulgaricus NBICCM 8244 and Streptococcus thermophilus NBIMCC 8253.
This feed additive is currently authorised under the category/functional 4(b) ‘zootechnical additives’/‘gut
ﬂora stabilisers’ according to the classiﬁcation system of Annex I of Regulation (EC) No 1831/2003 for
sucking piglets. In the current application, authorisation is sought under article 4 (1) of the Regulation
(EC) No 1831/2003 for the new use for chickens for fattening and rabbits suckling and weaned.
Probiotic lactina® is intended to be marketed as a freeze-dried powder containing a minimum total dose
of the sum of the six bacterial active substances (LAB) of 5 9 109 Colony Forming Units (CFU)/g. The
feed additive is intended to be used directly in feedingstuffs with a minimum total LAB content of
2.5 9 109 CFU/kg of complete feedingstuffs.
For the identiﬁcation and characterisation of the different bacterial strains, the Applicant proposed a
combination of classical phenotypic tests and modern molecular sequencing analysis. The EURL
recommends instead for ofﬁcial control the Pulsed Field Gel Electrophoresis (PFGE), a generally
recognised methodology for genetic identiﬁcation of bacterial strains.
For the enumeration of the sum of the six strains contained in Probiotic lactina® (feed additive), the
Applicant suggested the use of several International Dairy Federation (IDF) standards and the Bulgarian
Standard (BS) 10945, while the ring-trial validated spread plate method developed by CEN (EN 15787)
was suggested for the enumeration in feedingstuffs. This CEN method was already evaluated and
recommended by the EURL in several dossiers. Based on the performance characteristics available, the
EURL recommends for ofﬁcial control the EN 15787 spread plate method for the enumeration of the
sum of the six strains contained in Probiotic lactina® in the feed additive and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005, as last
amended by Regulation (EU) 2015/1761) is not considered necessary.
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